Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
4.050
+0.050 (1.25%)
May 2, 2025, 4:00 PM EDT - Market closed
Bionano Genomics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Bionano Genomics stock have an average target of 7.00, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 72.84% from the current stock price of 4.05.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bionano Genomics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +146.91% | Apr 9, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $1 → $4 | Hold | Maintains | $1 → $4 | -1.23% | Apr 2, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 10, 2024 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $360 → $60 | Buy → Hold | Downgrades | $360 → $60 | +1,381.48% | Aug 28, 2024 |
Financial Forecast
Revenue This Year
30.94M
from 30.78M
Increased by 0.53%
Revenue Next Year
34.10M
from 30.94M
Increased by 10.22%
EPS This Year
-8.45
from -88.13
EPS Next Year
-4.05
from -8.45
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 32.0M | 36.2M | 106.7M |
| Avg | 30.9M | 34.1M | 103.7M |
| Low | 29.4M | 32.0M | 99.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 4.1% | 17.1% | 212.9% |
| Avg | 0.5% | 10.2% | 204.0% |
| Low | -4.5% | 3.6% | 192.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -6.30 | -3.21 | -0.08 |
| Avg | -8.45 | -4.05 | -0.08 |
| Low | -10.05 | -5.02 | -0.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.